Marpai, NuvoAir partner to provide virtual COPD care to members

Marpai has thousands of members with COPD, asthma, heart failure

Steve Bryson, PhD avatar

by Steve Bryson, PhD |

Share this article:

Share article via email
A closeup of two hands shaking is illustrated.

Marpai, an artificial intelligence-powered administrator of employer health plans, is partnering with NuvoAir to provide virtual care for heart and lung conditions such as chronic obstructive pulmonary disease (COPD) to its health plan members and their families.

“We are thrilled to offer NuvoAir to address the high-cost heart and lung conditions facing members of health plans we manage,” Edmundo Gonzalez, Marpai’s CEO, said in a company press release. “With NuvoAir, members and their families can readily access care that can dramatically improve their health and quality of life and avoid high-cost emergency room visits and hospitalizations, which saves significant money for employers and their respective health plans.”

NuvoAir offers a virtual care model that combines best-in-class remote monitoring technology with a multidisciplinary virtual clinic. It is designed to improve patient outcomes, increase employee productivity, and save costs for employers and payors.

For COPD, a lung disease characterized by chronic inflammation and shortness of breath, NuvoAir offers mobile app-linked proprietary home monitoring devices, including a spirometer to assess lung function and an inhaler sensor to track how inhalers are used. This allows COPD patients to track their condition over time. NuvoAir’s clinical team also analyzes data to support treatment decisions. 

Recommended Reading
An illustration of person coughing, surrounded by clouds of dust.

COPD symptoms tend to worsen with outdoor air pollution: US study

Virtual monitoring services have led to fewer hospitalizations, life quality improvements

According to a pilot study in COPD patients, the use of NuvoAir’s virtual monitoring services was associated with a reduction in hospitalizations in 80% of patients, quality-of-life improvements in 87% of patients, and fewer self-reported disease exacerbations in 60%.

NuvoAir, which is currently available in 15 states, also is accessible for conditions such as asthma and chronic heart failure. Its members can access same-day appointments with specialists, including respiratory therapists, pulmonologists, cardiologists, nurses, health coaches, and care coordinators.

“Healthcare delivery often suffers from fragmentation, inefficiencies, and increased costs,” said Lorenzo Consoli, NuvoAir’s founder and CEO. “NuvoAir is dedicated to addressing these gaps, focusing on heart and lung care, with a commitment to leaving no patient behind.

“We’re excited to collaborate with Marpai, extending our innovative care model to members and their families, creating a best-in-class, value-based model that delivers improved outcomes and saves costs for Marpai’s clients.”

Marpai is a third-party administrator of self-funded employer health plans. They use proprietary artificial intelligence technology to proactively inform and educate plan members living with costly conditions. The company added NuvoAir to Marpai Connect, a care network with clinical care partners focused on preventing, mitigating, and reversing high-cost conditions.

Marpai has thousands of members with COPD, asthma, and heart failure, costing healthcare plans more than $12 million annually. The new partnership is expected to address the healthcare needs of employees and their families living with these conditions, which can be difficult to manage and costly.

“We are proud to have created a best-in-class value-based care model with NuvoAir to drive improved health outcomes for our members, and lower costs for our clients,” said Lutz Finger, Marpai’s president of product and technology.